Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Kim E M van Kessel, Department of Urology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands.
  • ,
  • Kirstin A van der Keur, Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands.
  • ,
  • Lars Dyrskjøt
  • Ferran Algaba, Section of Pathology, Fundacio Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain.
  • ,
  • Naeromy Y C Welvaart, Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands.
  • ,
  • Willemien Beukers, Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands.
  • ,
  • Ulrika Segersten, Department of Surgical Sciences, Thoracic Surgery, Uppsala University, Uppsala, Sweden.
  • ,
  • Bastian Keck, Department of Urology, University Hospital Erlangen, Friedrich Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • ,
  • Tobias Maurer, Department of Urology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
  • ,
  • Tatjana Simic, Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • ,
  • Marcus Horstmann, Department of Urology, Friedrich-Schiller-University Jena, Jena, Germany.
  • ,
  • Marc-Oliver Grimm, Department of Urology, Friedrich-Schiller-University Jena, Jena, Germany.
  • ,
  • Gregers G Hermann, Department of Urology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • ,
  • Karin Mogensen, Department of Urology, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • ,
  • Arndt Hartmann, Institute of Pathology, University Hospital Erlangen, Friedrich Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • ,
  • Niels Harving, Department of Urology, Aalborg University Hospital, Aalborg, Denmark.
  • ,
  • Astrid C Petersen, Department of Pathology, Aalborg University Hospital, 9100 Aalborg, Denmark.
  • ,
  • Jørgen B Jensen
  • Kerstin Junker, Department of Urology and Pediatric Urology, Saarland University Medical Center, 66424 Homburg, Germany.
  • ,
  • Joost L Boormans, Department of Urology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands.
  • ,
  • Francisco X Real, Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre, Madrid; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • ,
  • Núria Malats, Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, CIBERONC, Spain.
  • ,
  • Per-Uno Malmström, Department of Surgical Sciences, Thoracic Surgery, Uppsala University, Uppsala, Sweden.
  • ,
  • Torben F Ørntoft
  • Ellen C Zwarthoff, Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands. e.zwarthoff@erasmusmc.nl.
Original languageEnglish
JournalClinical Cancer Research
Volume24
Issue7
Pages (from-to)1586-1593
Number of pages8
ISSN1078-0432
DOIs
Publication statusPublished - 1 Apr 2018

    Research areas

  • FGFR3 MUTATION, GRADE, METHYLATION, PREDICTION, RECURRENCE, TBX2, UROTHELIAL CARCINOMA

See relations at Aarhus University Citationformats

ID: 126753785